Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
SNAPIST-I: ABI-007 for In-Stent Restenosis
NCT00093223Phase 2Completed
- Sponsor
- Celgene Corporation
- Start
- Sep 2001
- Primary completion
- Dec 2007
- Modality
- Polymer-based Nanoparticles, Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of nab-paclitaxel in coronary artery disease (CAD), angina pectoris, in-stent restenosis (ISR), sponsored by Celgene Corporation. Started Sep 2001; status: completed.
02
Drugs
nab-paclitaxel
03
Conditions
coronary artery disease (CAD)angina pectorisin-stent restenosis (ISR)
Beyond the preview
Go deeper on NCT00093223.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00093223.